Literature DB >> 22779681

Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues.

Chang-Zhi Dong1, Shaomin Tian, Won-Tak Choi, Santhosh Kumar, Dongxiang Liu, Yan Xu, Xiaofeng Han, Ziwei Huang, Jing An.   

Abstract

The replication of human immunodeficiency virus type 1 (n>an class="Species">HIV-1) can be profoundly inhibited by the natural ligands of two major HIV-1 coreceptors, CXCR4 and CCR5. Stromal cell-derived factor-1α (SDF-1α) is a natural ligand of CXCR4. We have recently developed a synthetic biology approach of using synthetically and modularly modified (SMM)-chemokines to dissect various aspects of the structure-function relationship of chemokines and their receptors. Here, we used this approach to design novel SMM-SDF-1α analogues containing unnatural N-methylated residues in the amino terminus to investigate whether the polypeptide main chain amide bonds in the N-terminus of SDF-1α play a role in SDF-1α signaling via CXCR4 and/or receptor internalization. The results show that SDF-1α analogues with a modified N-methylated main chain at position 2, 3, or 5 retain significant CXCR4 binding and yet completely lose signaling activities. Furthermore, a representative N-methylated analogue has been shown to be incapable of causing CXCR4 internalization. These results suggest that the ability of SDF-1α to activate CXCR4 signaling and internalization is dependent upon the main chain amide bonds in the N-terminus of SDF-1α. This study demonstrates the feasibility and value of applying a synthetic biology approach to chemically engineer natural proteins and peptide ligands as probes of important biological functions that are not addressed by other biological techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22779681      PMCID: PMC3891921          DOI: 10.1021/bi3003742

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  47 in total

1.  Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.

Authors:  Z Lu; J F Berson; Y Chen; J D Turner; T Zhang; M Sharron; M H Jenks; Z Wang; J Kim; J Rucker; J A Hoxie; S C Peiper; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor.

Authors:  P D Bieniasz; R A Fridell; I Aramori; S S Ferguson; M G Caron; B R Cullen
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

3.  Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation.

Authors:  R Förster; E Kremmer; A Schubel; D Breitfeld; A Kleinschmidt; C Nerl; G Bernhardt; M Lipp
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry.

Authors:  L Picard; D A Wilkinson; A McKnight; P W Gray; J A Hoxie; P R Clapham; R A Weiss
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

Review 5.  Human chemokines: an update.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.

Authors:  N Heveker; M Montes; L Germeroth; A Amara; A Trautmann; M Alizon; J Schneider-Mergener
Journal:  Curr Biol       Date:  1998-03-26       Impact factor: 10.834

8.  CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion.

Authors:  G Alkhatib; S S Ahuja; D Light; S Mummidi; E A Berger; S K Ahuja
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

9.  A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.

Authors:  B J Doranz; K Grovit-Ferbas; M P Sharron; S H Mao; M B Goetz; E S Daar; R W Doms; W A O'Brien
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.

Authors:  A Amara; S L Gall; O Schwartz; J Salamero; M Montes; P Loetscher; M Baggiolini; J L Virelizier; F Arenzana-Seisdedos
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  4 in total

Review 1.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

2.  High affinity CXCR4 inhibitors generated by linking low affinity peptides.

Authors:  Chaozai Zhang; Lina S Huang; Ruohan Zhu; Qian Meng; Siyu Zhu; Yan Xu; Huijun Zhang; Xiong Fang; Xingquan Zhang; Jiao Zhou; Robert T Schooley; Xiaohong Yang; Ziwei Huang; Jing An
Journal:  Eur J Med Chem       Date:  2019-04-01       Impact factor: 6.514

3.  GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation.

Authors:  Antonio Morales-Hernández; Chaïma Benaksas; Ashley Chabot; Claire Caprio; Maheen Ferdous; Xiwen Zhao; Guolian Kang; Shannon McKinney-Freeman
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

Review 4.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.